HomeTELO • CVE
add
Telo Genomics Corp
Previous close
$0.050
Day range
$0.050 - $0.050
Year range
$0.045 - $0.16
Market cap
5.02M CAD
Avg Volume
170.55K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 540.68K | -1.98% |
Net income | -541.68K | 2.00% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -537.92K | 1.52% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 486.51K | 48.20% |
Total assets | 606.90K | 37.87% |
Total liabilities | 633.60K | 57.20% |
Total equity | -26.70K | — |
Shares outstanding | 100.43M | — |
Price to book | ∞ | — |
Return on assets | -178.07% | — |
Return on capital | -553.66% | — |
Cash Flow
Net change in cash
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -541.68K | 2.00% |
Cash from operations | -300.71K | 35.69% |
Cash from investing | -2.08K | — |
Cash from financing | — | — |
Net change in cash | -302.78K | 35.27% |
Free cash flow | -99.65K | 61.71% |
About
Founded
2011
Headquarters
Website
Employees
8
